ストックスクリーナーアプリを入手
1.63
1.24%
0.02
前日終値:
$1.61
開ける：
$1.6
24時間の取引高:
982.71K
Relative Volume:
0.65
時価総額：
$111.99M
収益：
$832.00K
当期純損益:
$-135.12M
株価収益率:
-0.2677
EPS:
-6.09
ネットキャッシュフロー:
$-124.69M
1週間 パフォーマンス:
+7.95%
1か月 パフォーマンス:
-7.39%
6か月 パフォーマンス:
+13.19%
1年 パフォーマンス:
-22.01%
1日の値動き範囲:
$1.56
$1.67
1週間の範囲:
$1.475
$1.67
52週間の値動き範囲:
$1.30
$2.9789
Inovio Pharmaceuticals Inc Stock (INO) Company Profile
名前
Inovio Pharmaceuticals Inc
セクター
電話
(858) 410-3134
住所
660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA
INO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
INO
Inovio Pharmaceuticals Inc
|
1.63 | 110.61M | 832.00K | -135.12M | -124.69M | -6.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-09 | 開始されました | Piper Sandler | Overweight |
| 2024-05-14 | 開始されました | Stephens | Overweight |
| 2024-01-25 | アップグレード | Oppenheimer | Perform → Outperform |
| 2022-11-09 | ダウングレード | Maxim Group | Buy → Hold |
| 2022-11-01 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-07-19 | 再開されました | RBC Capital Mkts | Sector Perform |
| 2022-05-11 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-01-21 | アップグレード | BofA Securities | Underperform → Neutral |
| 2021-12-29 | 再開されました | Jefferies | Hold |
| 2021-09-10 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-06-24 | 開始されました | Jefferies | Hold |
| 2021-03-23 | 開始されました | BofA Securities | Neutral |
| 2021-02-12 | 開始されました | Oppenheimer | Outperform |
| 2020-11-17 | ダウングレード | ROTH Capital | Neutral → Sell |
| 2020-11-10 | アップグレード | ROTH Capital | Sell → Neutral |
| 2020-09-28 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2020-09-28 | アップグレード | Maxim Group | Hold → Buy |
| 2020-07-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2020-07-01 | ダウングレード | ROTH Capital | Neutral → Sell |
| 2020-06-29 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2020-06-26 | ダウングレード | Stifel | Buy → Hold |
| 2020-05-21 | 開始されました | The Benchmark Company | Buy |
| 2020-04-30 | ダウングレード | ROTH Capital | Buy → Neutral |
| 2020-03-13 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2020-03-13 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-12-19 | 開始されました | ROTH Capital | Buy |
| 2018-02-15 | 繰り返されました | Maxim Group | Buy |
| 2017-10-18 | 開始されました | RBC Capital Mkts | Outperform |
| 2017-09-06 | 開始されました | Citigroup | Buy |
| 2017-06-08 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2017-05-24 | 繰り返されました | Maxim Group | Buy |
| 2017-03-16 | アップグレード | Maxim Group | Hold → Buy |
| 2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
すべてを表示
Inovio Pharmaceuticals Inc (INO) 最新ニュース
Is Inovio Pharmaceuticals Inc a potential multi baggerEarnings Overview Report & Daily Stock Trend Watchlist - baoquankhu1.vn
Market Trends: What is the implied volatility of Match Group IncMarket Weekly Review & Comprehensive Market Scan Reports - baoquankhu1.vn
Guidance Update: Is Inovio Pharmaceuticals Inc a top pick in the sectorForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Is Inovio Pharmaceuticals Inc.’s ROIC above industry average2025 Dividend Review & Free Long-Term Investment Growth Plans - mfd.ru
Market Sentiment Around Loss-Making Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Yahoo Finance
Investment Report: What are TIGRs recent SEC filings showingShare Buyback & Community Consensus Picks - baoquankhu1.vn
Inovio Pharmaceuticals Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Inovio Extends Series A Warrants, Enhancing Capital Flexibility - TipRanks
Inovio (NASDAQ: INO) extends Series A warrant expiration to March 31, 2026 - Stock Titan
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
DNA Vaccines Market to Reach US$ 6.82 Billion by 2033 at 18.5% - openPR.com
S P Trends: What are Inovio Pharmaceuticals Incs growth levers2025 Price Targets & Verified Stock Trade Ideas - baoquankhu1.vn
INO-3107 At The Crossroads: FDA Review Drives Inovio's Upside And Risk (NASDAQ:INO) - Seeking Alpha
Published on: 2026-01-22 09:38:42 - baoquankhu1.vn
INO Investor Notice: Levi & Korsinsky Investigates Inovio Pharmaceuticals, Inc. for Securities Law Violations - TMX Newsfile
Risks Report: Is Inovio Pharmaceuticals Inc stock good for income investorsJuly 2025 Sentiment & Expert Approved Trade Ideas - baoquankhu1.vn
*CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - FinancialContent
Aug Swings: Is Inovio Pharmaceuticals Inc a potential multi baggerJuly 2025 Trends & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Growth Report: Is BZAI stock a smart retirement pickMarket Volume Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
Breakout Zone: Can Inovio Pharmaceuticals Inc outperform in the next rally2025 Market WrapUp & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Setups: Is Inovio Pharmaceuticals Inc. a potential multi baggerPortfolio Gains Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Market Wrap: Is Inovio Pharmaceuticals Inc part of any major indexJuly 2025 Rallies & Expert-Curated Trade Recommendations - baoquankhu1.vn
CORRECTION*INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - Chartmill
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - FinancialContent
INOVIO issues equity award to new hire as it rebuilds for its next act - MSN
Inovio Pharmaceuticals: Speculative Buy Thesis Hinges On INO-3107 (NASDAQ:INO) - Seeking Alpha
INO-3107 shows promise in reducing surgeries for RRP patients - MSN
Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividend2025 Investor Takeaways & Low Risk Growth Stock Ideas - Улправда
Inovio Pharmaceuticals Inc. Stock Underperforms Thursday When Compared To Competitors - 富途牛牛
Why retail investors pile into Inovio Pharmaceuticals Inc. stockJuly 2025 Decliners & Real-Time Buy Zone Alerts - ulpravda.ru
Retail Trends: Will Inovio Pharmaceuticals Inc. (GBM) stock announce special dividendMarket Performance Recap & Daily Price Action Insights - Улправда
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio Pharmaceuticals, Inc.INO - PR Newswire
AstraZeneca pullback hits Inovio shares - The Pharma Letter
Looking Into Inovio Pharmaceuticals Inc's Recent Short Interest - Sahm
INOVIO announces pricing of $25M public offering - MSN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Inovio ... - Bluefield Daily Telegraph
Upcoming Events - FinancialContent
Inovio Pharmaceuticals Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - Early Times
Ksolves India Limited Bounces Off Moving Average SupportStock Correlation Metrics & Superior Return Stocks - earlytimes.in
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
FDA sets 2026 decision clock for INOVIO’s rare disease therapy - MSN
U.S., U.K. Strike Drug Pricing Deal Aimed at Ending Transatlantic Imbalance - MyChesCo
INOVIO Reports Inducement Grant Under Inducement Plan - Eastern Progress
RSI Check: Will Inovio Pharmaceuticals Inc GBM stock announce special dividendEarnings Recap Summary & Free Verified High Yield Trade Plans - moha.gov.vn
FDA Sets 2026 Decision Clock for INOVIO’s Rare Disease Therapy - MyChesCo
Inovio respiratory DNA drug candidate shows promise in early trial - MSN
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Inovio drops as respiratory papillomatosis asset denied accelerated review - MSN
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Inovio Pharmaceuticals Inc (INO) 財務データ
収益
当期純利益
現金流量
EPS
1.27%
大文字化:
|
ボリューム (24 時間):